The Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia Joshua LukenbillAnjali S. Advani Acute Leukemias (F Ravandi, Section Editor) 05 April 2013 Pages: 91 - 97
Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia A. K. FieldingG. A. Zakout Acute Leukemias (E Feldman, Section Editor) 09 March 2013 Pages: 98 - 108
Is Minimal Residual Disease Monitoring Clinically Relevant in Adults with Acute Myelogenous Leukemia? Karen-Sue B. CarlsonMonica L. Guzman Acute Leukemias (E Feldman, Section Editor) 06 April 2013 Pages: 109 - 115
Acute Myeloid Leukemia Following a Myeloproliferative Neoplasm: Clinical Characteristics, Genetic Features and Effects of Therapy Mark L. HeaneyGabriela Soriano Acute Leukemias (E Feldman, Section Editor) 10 April 2013 Pages: 116 - 122
Novel Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia – A Focus on Emerging Monoclonal Antibodies Naval DaverSusan O’Brien Acute Leukemias (F Ravandi, Section Editor) 29 March 2013 Pages: 123 - 131
Strategies to Reduce Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Raya MawadJack M. LionbergerJohn M. Pagel Acute Leukemias (E Feldman, Section Editor) 03 March 2013 Pages: 132 - 140
High-Dose Cytarabine (HD araC) in the Treatment of Leukemias: a Review Nicholas D. ReeseGary J. Schiller Acute Leukemias (E Feldman, Section Editor) 12 May 2013 Pages: 141 - 148
Are Results of Targeted Gene Sequencing Ready to Be Used for Clinical Decision Making for Patients with Acute Myelogenous Leukemia? Arati V. RaoB. Douglas Smith Acute Leukemias (F Ravandi, Section Editor) 18 April 2013 Pages: 149 - 155
Developmental Therapeutics in Acute Myelogenous Leukemia: Are There Any New Effective Cytotoxic Chemotherapeutic Agents Out There? Alice MimsRobert K. Stuart Acute Leukemias (E Feldman, Section Editor) 03 May 2013 Pages: 156 - 162